Korro Bio, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Korro Bio, Inc. (KRRO) had Deferred Tax Assets, Goodwill and Intangible Assets of $478.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2023-03-10
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $478.00K.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $392.00K.
- 2020-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $360.00K.
- 2019-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $358.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2022-12-31 | $478.00K 10-K · filed 2023-03-10 |
| 2021-12-31 | $392.00K 10-K · filed 2023-03-10 |
| 2020-12-31 | $360.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | $358.00K 10-K · filed 2021-03-29 |
| 2018-12-31 | $256.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |